» Articles » PMID: 12486107

Lipopolysaccharide-enhanced, Toll-like Receptor 4-dependent T Helper Cell Type 2 Responses to Inhaled Antigen

Overview
Journal J Exp Med
Date 2002 Dec 18
PMID 12486107
Citations 459
Authors
Affiliations
Soon will be listed here.
Abstract

Allergic asthma is an inflammatory lung disease initiated and directed by T helper cells type 2 (Th2). The mechanism involved in generation of Th2 responses to inert inhaled antigens, however, is unknown. Epidemiological evidence suggests that exposure to lipopolysaccharide (LPS) or other microbial products can influence the development and severity of asthma. However, the mechanism by which LPS influences asthma pathogenesis remains undefined. Although it is known that signaling through Toll-like receptors (TLR) is required for adaptive T helper cell type 1 (Th1) responses, it is unclear if TLRs are needed for Th2 priming. Here, we report that low level inhaled LPS signaling through TLR4 is necessary to induce Th2 responses to inhaled antigens in a mouse model of allergic sensitization. The mechanism by which LPS signaling results in Th2 sensitization involves the activation of antigen-containing dendritic cells. In contrast to low levels, inhalation of high levels of LPS with antigen results in Th1 responses. These studies suggest that the level of LPS exposure can determine the type of inflammatory response generated and provide a potential mechanistic explanation of epidemiological data on endotoxin exposure and asthma prevalence.

Citing Articles

Mast cell - tumor cell interaction related gene and microRNA expression profiles in oral squamous cell carcinoma.

Khromov T, Sitte M, Salinas G, Schminke B, Fischer A, Schliephake H Front Oncol. 2025; 15:1518404.

PMID: 40061903 PMC: 11885139. DOI: 10.3389/fonc.2025.1518404.


Harnessing the Farm Effect: Microbial Products for the Treatment and Prevention of Asthma Throughout Life.

Hollinger M, Grayson E, Ferreira C, Sperling A Immunol Rev. 2025; 330(1):e70012.

PMID: 40035333 PMC: 11877632. DOI: 10.1111/imr.70012.


Tissue-Resident Th2 Cells in Type 2 Immunity and Allergic Diseases.

Mannion J, Rahimi R Immunol Rev. 2025; 330(1):e70006.

PMID: 39981858 PMC: 11897987. DOI: 10.1111/imr.70006.


Allergens in Atopic Dermatitis.

Zhang J, Li G, Guo Q, Yang Y, Yang J, Feng X Clin Rev Allergy Immunol. 2025; 68(1):11.

PMID: 39924626 DOI: 10.1007/s12016-025-09024-7.


The Long-Term Immunity of a Microneedle Array Patch of a SARS-CoV-2 S1 Protein Subunit Vaccine Irradiated by Gamma Rays in Mice.

Kim E, Khan M, Shin J, Huang S, Ferrari A, Han D Vaccines (Basel). 2025; 13(1).

PMID: 39852865 PMC: 11768753. DOI: 10.3390/vaccines13010086.


References
1.
COHN L, Homer R, Niu N, Bottomly K . T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J Exp Med. 1999; 190(9):1309-18. PMC: 2195688. DOI: 10.1084/jem.190.9.1309. View

2.
Tsitoura D, DeKruyff R, Lamb J, Umetsu D . Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J Immunol. 1999; 163(5):2592-600. View

3.
Wan G, Li C, Lin R . Airborne endotoxin exposure and the development of airway antigen-specific allergic responses. Clin Exp Allergy. 2000; 30(3):426-32. DOI: 10.1046/j.1365-2222.2000.00730.x. View

4.
Herrick C, Macleod H, Glusac E, Tigelaar R, Bottomly K . Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest. 2000; 105(6):765-75. PMC: 377464. DOI: 10.1172/JCI8624. View

5.
Tulic M, Wale J, Holt P, Sly P . Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol. 2000; 22(5):604-12. DOI: 10.1165/ajrcmb.22.5.3710. View